With steady prematurity rates and increasing number of surviving extremely preterm infants, the risk to develop encephalopathy of prematurity characterised by white matter (WM) injury, WM loss and subsequent abnormalities in cortical development and long-term neurodevelopmental delay, has become a major concern in neonatal care (1). Erythropoietin (EPO) is known to be neuroprotective. The aim of this study is to demonstrate that early EPO treatment of premature babies has a neuroprotective effect that can be seen on MRI at term equivalent age (TEA).
